| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.01 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |